Resources Available for Patients with HIV Drug Resistance

Opinion
Video

The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.

BIC = bictegravir

DRV = darunavir

DTG = dolutegravir

F/TAF = FTC/TAF = Emtricitabine/Tenofovir alafenamide

F/TDF = FTC/TDF = Emtricitabine/Tenofovir disoproxil fumarate

B/F/TAF = BIC/FTC/TAF = Bictegravir/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

DTG/ABC/3TC = Dolutegravir/Abacavir/Lamivudine (single tablet regimen)

DTG + F/TAF = DTG + FTC/TAF = Dolutegravir + Emtricitabine/Tenofovir alafenamide (multi-tablet regimen)

D/C/F/TAF = DRV/COBI/FTC/TAF = Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

DTG/3TC = Dolutegravir/Lamivudine (single tablet regimen)

CAB = Cabotegravir

CAB + RPV = Cabotegravir + Rilpivirine

Video content above is prompted by the following question:

  • When resistance occurs, what resources can health care providers use to help patients in their treatment journey?
Related Videos
A panel of 4 experts on asthma
A panel of 4 experts on asthma
4 KOLs are featured in this series
4 KOLs are featured in this series
Shauna Applin, ARNP, an expert on HIV
Shauna Applin, ARNP, an expert on HIV
3 KOLs are featured in this program.
3 KOLs are featured in this program.
A panel of 4 experts on HIV
A panel of 4 experts on asthma
© 2024 MJH Life Sciences

All rights reserved.